Ronald A. Morton
Keine laufenden Positionen mehr
Profil
Ronald A.
Morton worked as the Director of Baylor Adult Urology Program at Baylor College of Medicine from 1994 to 2003.
He then worked as the Director of Urologic Oncology at The Cancer Institute of New Jersey from 2004 to 2007.
He was also the Director at Innova Memphis, Inc. and the Chief Medical Officer & Vice President at GTx, Inc. Lastly, he worked as a Professor of Surgery at the University of Medicine & Dentistry of New Jersey.
Morton received his undergraduate and doctorate degrees from The Johns Hopkins University.
Ehemalige bekannte Positionen von Ronald A. Morton
| Unternehmen | Position | Ende |
|---|---|---|
The Cancer Institute of New Jersey
 The Cancer Institute of New Jersey Hospital/Nursing ManagementHealth Services The Cancer Institute of New Jersey operates as a cancer centre. The firm offers cancer care for adults and children, providing access to the medicines and treatment options. It also offers clinical, patient education resources and support services. The company was founded in and is headquartered in New Brunswick, NJ. | Corporate Officer/Principal | 01.04.2007 |
| Baylor College of Medicine | Corporate Officer/Principal | 01.01.2003 |
Innova Memphis, Inc.
 Innova Memphis, Inc. Investment ManagersFinance Innova Memphis Inc (Innova Memphis) is a venture capital subsidiary of Memphis Bioworks Foundation founded in 2007. The firm is headquartered in Memphis, Tennessee. | Private Equity Investor | - |
| University of Medicine & Dentistry of New Jersey | Corporate Officer/Principal | - |
GTx, Inc.
 GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Ronald A. Morton
| The Johns Hopkins University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
GTx, Inc.
GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN. | Health Technology |
The Cancer Institute of New Jersey
The Cancer Institute of New Jersey Hospital/Nursing ManagementHealth Services The Cancer Institute of New Jersey operates as a cancer centre. The firm offers cancer care for adults and children, providing access to the medicines and treatment options. It also offers clinical, patient education resources and support services. The company was founded in and is headquartered in New Brunswick, NJ. | Health Services |
Innova Memphis, Inc.
Innova Memphis, Inc. Investment ManagersFinance Innova Memphis Inc (Innova Memphis) is a venture capital subsidiary of Memphis Bioworks Foundation founded in 2007. The firm is headquartered in Memphis, Tennessee. | Finance |
